Experimental data and PBPK modeling quantify antibody interference in PEGylated drug carrier delivery
From MaRDI portal
Publication:2051453
Recommendations
- scientific article; zbMATH DE number 1254061
- A computational investigation of the ventilation structure and maximum rate of metabolism for a physiologically based pharmacokinetic (PBPK) model of inhaled xylene
- Uncertainty, Variability, and Sensitivity Analysis in Physiological Pharmacokinetic Models
- Evaluation of the whole body physiologically based pharmacokinetic (WB-PBPK) modeling of drugs
- A mechanistic compartmental model for total antibody uptake in tumors
Cites work
Cited in
(4)- Evaluation of the whole body physiologically based pharmacokinetic (WB-PBPK) modeling of drugs
- Mathematical analysis of the pharmacokinetic-pharmacodynamic (PKPD) behaviour of monoclonal antibodies: predicting \textit{in vivo} potency
- RECEPTOR-MEDIATED ENDOCYTOSIS MODELING OF ANTIBODY-DRUG CONJUGATES TO THE RELEASED PAYLOAD WITHIN THE INTRACELLULAR SPACE CONSIDERING TARGET ANTIGEN EXPRESSION LEVELS
- Local identifiability analysis, parameter subset selection and verification for a minimal brain PBPK model
This page was built for publication: Experimental data and PBPK modeling quantify antibody interference in PEGylated drug carrier delivery
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2051453)